Clorox Co (CLX) Shares Bought by AE Wealth Management LLC
AE Wealth Management LLC grew its stake in Clorox Co (NYSE:CLX) by 15.3% in the fourth quarter, Holdings Channel reports. The fund owned 6,438 shares of the company’s stock after acquiring an additional 856 shares during the period. AE Wealth Management LLC’s holdings in Clorox were worth $958,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors also recently made changes to their positions in the business. Phocas Financial Corp. acquired a new stake in shares of Clorox during the 2nd quarter worth approximately $167,000. Private Asset Management Inc. acquired a new position in Clorox during the fourth quarter valued at approximately $208,000. Lourd Capital LLC acquired a new position in Clorox during the fourth quarter valued at approximately $210,000. ZWJ Investment Counsel Inc. acquired a new position in Clorox during the fourth quarter valued at approximately $216,000. Finally, Northstar Investment Advisors LLC acquired a new position in Clorox during the fourth quarter valued at approximately $222,000. 73.68% of the stock is owned by institutional investors.
Clorox Co (NYSE CLX) opened at $128.80 on Friday. The firm has a market cap of $16,670.00, a P/E ratio of 21.22, a PEG ratio of 2.60 and a beta of 0.31. Clorox Co has a 1-year low of $124.09 and a 1-year high of $150.40. The company has a quick ratio of 0.86, a current ratio of 1.22 and a debt-to-equity ratio of 2.35.
The firm also recently disclosed a quarterly dividend, which was paid on Friday, February 9th. Stockholders of record on Wednesday, January 24th were given a $0.84 dividend. This represents a $3.36 dividend on an annualized basis and a dividend yield of 2.61%. The ex-dividend date was Tuesday, January 23rd. Clorox’s dividend payout ratio is presently 55.35%.
In other news, SVP Michael R. Costello sold 10,574 shares of the business’s stock in a transaction on Tuesday, November 28th. The shares were sold at an average price of $136.01, for a total value of $1,438,169.74. Following the sale, the senior vice president now owns 34,867 shares of the company’s stock, valued at $4,742,260.67. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Insiders own 1.00% of the company’s stock.
A number of research analysts recently issued reports on the stock. Argus cut shares of Clorox from a “buy” rating to a “hold” rating and decreased their price objective for the company from $150.40 to $127.81 in a report on Thursday. Zacks Investment Research upgraded shares of Clorox from a “hold” rating to a “buy” rating and set a $147.00 price objective for the company in a report on Tuesday. BMO Capital Markets set a $147.00 price objective on shares of Clorox and gave the company a “buy” rating in a report on Monday, February 5th. Bank of America decreased their price objective on shares of Clorox from $155.00 to $140.00 and set a “neutral” rating for the company in a report on Monday, February 5th. Finally, Morgan Stanley reduced their price target on shares of Clorox from $140.00 to $133.00 and set an “equal weight” rating for the company in a report on Monday, February 5th. Two investment analysts have rated the stock with a sell rating, eleven have issued a hold rating and four have given a buy rating to the company. The stock presently has a consensus rating of “Hold” and an average price target of $131.97.
Clorox Company Profile
The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Co (NYSE:CLX).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.